Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00105885 · ClinicalTrials.gov registry record · NA

Telephone Care as a Substitute for Routine Psychiatric Medication

A NA study, sponsored by US Department of Veterans Affairs.

Completed
Registry status
NA
Development phase
324
Enrollment target

NCT00105885: Completed NA study, sponsored by US Department of Veterans Affairs.

NCT00105885 is a NA study that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 324 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (77% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00105885, a NA study, has completed, sponsored by US Department of Veterans Affairs.

COMPLETED
Registry status
NA
Development phase
324 participants
Enrollment target

Study Summary

The purpose of this study is to answer the following questions: (1) Does substituting brief, scheduled, clinician-initiated telephone calls (telephone care) for routine psychiatric medication management visits reduce overall healthcare utilization? (2) Is substituting brief, scheduled, clinician-initiated telephone calls (telephone care) for routine psychiatric medication management visits as effective as routine care?

Interventions

  • PROCEDURE telephone care

Trial Details

FieldValue
Enrollment Target 324 participants
Start Date 2003-11
Est. Completion 2008-09
Phase NA
US Department of Veterans Affairs

632 total trials

What the finished NCT00105885 record still lists

NCT00105885 is an interventional study that assigns participants to a tested intervention. The registered 324 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (77% lower).

The record links to 0 conditions, and to 1 intervention - of which telephone care is the first listed.

NCT00105885 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00105885 about?

NCT00105885 is a clinical study titled "Telephone Care as a Substitute for Routine Psychiatric Medication". The purpose of this study is to answer the following questions: (1) Does substituting brief, scheduled, clinician-initiated telephone calls (telephone care) for routine psychiatric medication management visits reduce overall healthcare utilization? (2) Is substituting brief, scheduled, clinician-ini...

What is the current status of trial NCT00105885?

This trial is currently completed. It is a NA study. The enrollment target is 324 participants. The study started on 2003-11. Estimated completion is 2008-09.

What interventions are being tested in trial NCT00105885?

The interventions under investigation include: telephone care (PROCEDURE).

Who is sponsoring clinical trial NCT00105885?

This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00105885's enrollment target sits among peer trials

324 312th of 2000 higher than 1,686 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04164173 · 324 participants · NA

    Hyperinflation Respiratory Therapies in Cardiac Surgery Patients

  • NCT04708054 · 324 participants · Phase 2

    Venetoclax to Improve Outcomes of Fractionated Busulfan Regimen in Patients With High-Risk AML and MDS

  • NCT05261399 · 324 participants · Phase 3

    Savolitinib Plus Osimertinib Versus Platinum-based Doublet Chemotherapy in Participants With Non-Small Cell Lung Cancer Who Have Progressed on Osimertinib Treatment

  • NCT05353322 · 324 participants · NA

    Breaking up Prolonged Sedentary Behavior to Improve Cardiometabolic Health

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00105885, the US trial registry maintained by the National Library of Medicine. NCT00105885 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.